CopyMark Law Group
4.9/5
Drawing for AKTIS

USPTO serial 90622804

AKTIS

Reviewed by CopyMark Law Group

Reg. 8355795Status 700Registered
Filing date
Status date
Registration date
Jul 21, 2026
Examiner
LE, KHANH M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AKTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vincent J. Badolato

Vincent J. Badolato BROWN RUDNICK LLP1900 N Street NW, 4th FloorWashington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
042Providing medical research and scientific research information in the field of radio pharmacological oncology via the Internet; Providing medical and scientific research information in the field of radio pharmacology clinical trials; Providing medical and scientific research information in the field of radiopharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of radiopharmaceuticals and genetics; Scientific investigations for medical purposes in the field of radiopharmacology; Scientific research and development in the field of radiopharmacologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 21, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 29, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 29, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 9, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 26, 2026IUAFUSE AMENDMENT FILED—
May 26, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2025EX5GSOU EXTENSION 5 GRANTED—
Nov 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 13, 2025EXT5SOU EXTENSION 5 FILED—
May 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2025EX4GSOU EXTENSION 4 GRANTED—
May 2, 2025EXT4SOU EXTENSION 4 FILED—
May 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 11, 2024EX3GSOU EXTENSION 3 GRANTED—
Oct 11, 2024EXT3SOU EXTENSION 3 FILED—
Oct 11, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 6, 2024EX2GSOU EXTENSION 2 GRANTED—
May 6, 2024EXT2SOU EXTENSION 2 FILED—
May 6, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 29, 2024EX1GSOU EXTENSION 1 GRANTED—
Feb 28, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 5, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Jan 5, 2024TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 5, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Jan 5, 2024PETGPETITION TO REVIVE-GRANTED—
Jan 5, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Dec 26, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 25, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 30, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 24, 2023EXT1SOU EXTENSION 1 FILED—
May 23, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 11, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 11, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Apr 11, 2023OP.DOPPOSITION DISMISSED NO. 999999—
Feb 28, 2022OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 3, 2022DOCKASSIGNED TO EXAMINER—
Nov 30, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 13, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2021DOCKASSIGNED TO EXAMINER—
Jul 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance